Joachim P. Steinbach
Dr. Senckenberg Institute Of Neurooncology, Frankfurt
Frankfurt Am Main, HE, Germany
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 195 publications
Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.
Journal: Nature cancer
Published: August 03, 2026
Mental health and suicidality in glioblastoma patients in germany - a multicenter cross-sectional observational study protocol (SHINE-GLIO Study).
Journal: Neurological research and practice
Published: June 29, 2026
Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.
Journal: Acta neuropathologica communications
Published: June 02, 2026
Ligand-based CAR design enhances durability of CD70-targeted CAR T cells in glioblastoma.
Journal: Molecular therapy. Oncology
Published: March 02, 2026
Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.
Journal: Neuro-oncology advances
Published: February 20, 2026
Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort.
Journal: Acta neuropathologica communications
Published: December 23, 2025
Publisher Correction: State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis.
Journal: Neurological research and practice
Published: December 16, 2025
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.
Journal: Neuro-oncology
Published: December 04, 2025
In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T.
Journal: Cancer & metabolism
Published: November 12, 2025
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.
Journal: Nature cancer
Published: October 30, 2025
State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis.
Journal: Neurological research and practice
Published: September 06, 2025
Targeting glioblastoma mitochondrial metabolism with S-Gboxin induces cytotoxicity under conditions of the tumor microenvironment.
Journal: Cell death discovery
Published: August 27, 2025
Last Updated: 09/26/2026